Comparison of 5-hydroxytryptophan signaling pathway characteristics in diarrhea-predominant irritable bowel syndrome and ulcerative colitis

doi:10.3748/wjg.v22.i12.3451

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 22, Issue 12

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (7620)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-5) series, Tables (1-7) series.

Item

Count

PDF

618

WORD

318

HTML

4451

Figures (1-5)

189

Tables (1-7)

176

Sum=5752

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

731

Download

1137

Sum=1868

Mar 28, 2016 (publication date) through Jul 29, 2024

Times Cited of This Article

Times Cited (24)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Prospective Study

World J Gastroenterol. Mar 28, 2016; 22(12): 3451-3459
Published online Mar 28, 2016. doi: 10.3748/wjg.v22.i12.3451

Table 4 Comparison of 5-HT and 5-HIAA concentrations in each group (mean ± SD)

	5-HT (nmol/L)	5-HIAA (nmol/L)
Normal	10.55 ± 1.35	1.15 ± 0.15
IBS-D	35.31 ± 2.15^a	8.50 ± 1.50^a
UC in remission	33.85 ± 1.55^a	8.15 ± 1.35^a

^aP < 0.05 vs normal. UC: Ulcerative colitis; IBS-D: Diarrhea-predominant irritable bowel syndrome.

Citation: Yu FY, Huang SG, Zhang HY, Ye H, Chi HG, Zou Y, Lv RX, Zheng XB. Comparison of 5-hydroxytryptophan signaling pathway characteristics in diarrhea-predominant irritable bowel syndrome and ulcerative colitis. World J Gastroenterol 2016; 22(12): 3451-3459
URL: https://www.wjgnet.com/1007-9327/full/v22/i12/3451.htm
DOI: https://dx.doi.org/10.3748/wjg.v22.i12.3451